News
Wednesday, 18 September 2019
In mid-August the FDA approved the novel compound pretomanid for the treatment of XDR-TB and the treatment of MDR-TB for patients intolerant of, or not responding to, standard MDR-TB treatment.
Publication Date:
Sun, 01 Sep 2019 - 16:30
We are often asked about the safety of sunscreens. The American Academy of Dermatology have put together a very helpful set of ‘frequently asked questions’.
Publication Date:
Sun, 01 Sep 2019 - 16:30
A fascinating new systematic review of meta-analyses and trials assessing the efficacy of nutritional supplements has shown some interesting results.
Publication Date:
Sun, 01 Sep 2019 - 16:30
A medicine safety letter highlights the risk of acute kidney injury in patients treated with fluoroquinolones concomitantly with ace-inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).
Publication Date:
Fri, 02 Aug 2019 - 11:30